3 E NETWORK TECHNOLOGY GRP-A (MASK) Fundamental Analysis & Valuation

NASDAQ:MASK • VGG8849D1289

Current stock price

1.67 USD
-0.02 (-1.18%)
At close:
1.62 USD
-0.05 (-2.99%)
Pre-Market:

This MASK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MASK Profitability Analysis

1.1 Basic Checks

  • In the past year MASK was profitable.
  • MASK had a positive operating cash flow in the past year.
MASK Yearly Net Income VS EBIT VS OCF VS FCFMASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 500K 1M 1.5M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 19.61%, MASK belongs to the top of the industry, outperforming 95.51% of the companies in the same industry.
  • MASK has a better Return On Equity (34.26%) than 92.13% of its industry peers.
  • MASK's Return On Invested Capital of 40.30% is amongst the best of the industry. MASK outperforms 98.88% of its industry peers.
Industry RankSector Rank
ROA 19.61%
ROE 34.26%
ROIC 40.3%
ROA(3y)32.62%
ROA(5y)N/A
ROE(3y)51.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MASK Yearly ROA, ROE, ROICMASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 50 100

1.3 Margins

  • MASK has a better Profit Margin (23.03%) than 95.51% of its industry peers.
  • In the last couple of years the Profit Margin of MASK has declined.
  • MASK has a Operating Margin of 39.87%. This is amongst the best in the industry. MASK outperforms 98.88% of its industry peers.
  • MASK's Operating Margin has improved in the last couple of years.
  • MASK's Gross Margin of 50.26% is fine compared to the rest of the industry. MASK outperforms 75.28% of its industry peers.
  • MASK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 39.87%
PM (TTM) 23.03%
GM 50.26%
OM growth 3Y1.96%
OM growth 5YN/A
PM growth 3Y-22.43%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
MASK Yearly Profit, Operating, Gross MarginsMASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 500 1K 1.5K 2K 2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MASK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MASK is creating value.
  • MASK has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MASK is higher compared to a year ago.
MASK Yearly Shares OutstandingMASK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 200K 400K 600K 800K 1M
MASK Yearly Total Debt VS Total AssetsMASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • MASK has an Altman-Z score of 3.31. This indicates that MASK is financially healthy and has little risk of bankruptcy at the moment.
  • MASK has a Altman-Z score of 3.31. This is in the better half of the industry: MASK outperforms 67.42% of its industry peers.
  • MASK has a debt to FCF ratio of 78.28. This is a negative value and a sign of low solvency as MASK would need 78.28 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 78.28, MASK is not doing good in the industry: 60.67% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.20 indicates that MASK is not too dependend on debt financing.
  • MASK has a Debt to Equity ratio (0.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 78.28
Altman-Z 3.31
ROIC/WACC3.93
WACC10.25%
MASK Yearly LT Debt VS Equity VS FCFMASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.3 Liquidity

  • A Current Ratio of 2.46 indicates that MASK has no problem at all paying its short term obligations.
  • MASK has a better Current ratio (2.46) than 70.79% of its industry peers.
  • MASK has a Quick Ratio of 2.46. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
  • MASK has a Quick ratio of 2.46. This is in the better half of the industry: MASK outperforms 70.79% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 2.46
MASK Yearly Current Assets VS Current LiabilitesMASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MASK Growth Analysis

3.1 Past

  • MASK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.29%, which is quite good.
  • Measured over the past years, MASK shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.89% on average per year.
  • The Revenue has grown by 107.85% in the past year. This is a very strong growth!
  • MASK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.08% yearly.
EPS 1Y (TTM)19.29%
EPS 3Y22.89%
EPS 5YN/A
EPS Q2Q%-47.67%
Revenue 1Y (TTM)107.85%
Revenue growth 3Y55.08%
Revenue growth 5YN/A
Sales Q2Q%462.69%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MASK Yearly Revenue VS EstimatesMASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

4

4. MASK Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 0.40, the valuation of MASK can be described as very cheap.
  • Based on the Price/Earnings ratio, MASK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of MASK to the average of the S&P500 Index (26.91), we can say MASK is valued rather cheaply.
Industry RankSector Rank
PE 0.4
Fwd PE N/A
MASK Price Earnings VS Forward Price EarningsMASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MASK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 139.17
EV/EBITDA N/A
MASK Per share dataMASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • MASK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MASK Dividend Analysis

5.1 Amount

  • MASK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MASK Fundamentals: All Metrics, Ratios and Statistics

3 E NETWORK TECHNOLOGY GRP-A

NASDAQ:MASK (4/28/2026, 8:00:00 PM)

Premarket: 1.62 -0.05 (-2.99%)

1.67

-0.02 (-1.18%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners4.67%
Inst Owner ChangeN/A
Ins Owners27.27%
Ins Owner Change0%
Market Cap1.92M
Revenue(TTM)7.96M
Net Income(TTM)1.83M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.4
Fwd PE N/A
P/S 0.24
P/FCF 139.17
P/OCF 139.17
P/B 0.36
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)4.18
EY250.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY0.72%
OCF(TTM)0.01
OCFY0.72%
SpS6.92
BVpS4.66
TBVpS4.66
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.9248 (1152.98%)
Profitability
Industry RankSector Rank
ROA 19.61%
ROE 34.26%
ROCE 49.35%
ROIC 40.3%
ROICexc 42.37%
ROICexgc 42.37%
OM 39.87%
PM (TTM) 23.03%
GM 50.26%
FCFM 0.17%
ROA(3y)32.62%
ROA(5y)N/A
ROE(3y)51.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-24.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.87%
ROICexc growth 5YN/A
OM growth 3Y1.96%
OM growth 5YN/A
PM growth 3Y-22.43%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 78.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 0.75%
Current Ratio 2.46
Quick Ratio 2.46
Altman-Z 3.31
F-Score4
WACC10.25%
ROIC/WACC3.93
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)10.33%
Cap/Sales(5y)N/A
Profit Quality(3y)50.38%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.29%
EPS 3Y22.89%
EPS 5YN/A
EPS Q2Q%-47.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)107.85%
Revenue growth 3Y55.08%
Revenue growth 5YN/A
Sales Q2Q%462.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y95.9%
EBIT growth 3Y58.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.51%
FCF growth 3Y-75.5%
FCF growth 5YN/A
OCF growth 1Y-98.51%
OCF growth 3Y-75.8%
OCF growth 5YN/A

3 E NETWORK TECHNOLOGY GRP-A / MASK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for 3 E NETWORK TECHNOLOGY GRP-A?

ChartMill assigns a fundamental rating of 5 / 10 to MASK.


What is the valuation status for MASK stock?

ChartMill assigns a valuation rating of 4 / 10 to 3 E NETWORK TECHNOLOGY GRP-A (MASK). This can be considered as Fairly Valued.


What is the profitability of MASK stock?

3 E NETWORK TECHNOLOGY GRP-A (MASK) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MASK stock?

The Price/Earnings (PE) ratio for 3 E NETWORK TECHNOLOGY GRP-A (MASK) is 0.4 and the Price/Book (PB) ratio is 0.36.